Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical features and prognostic factors in Covid-19: A prospective cohort study
Sanne de Bruin, Lieuwe D. J. Bos, Marian A. van Roon, et al.
EBioMedicine (2021) Vol. 67, pp. 103378-103378
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

A guide to immunotherapy for COVID-19
Frank L. van de Veerdonk, Evangelos J. Giamarellos‐Bourboulis, Peter Pickkers, et al.
Nature Medicine (2022) Vol. 28, Iss. 1, pp. 39-50
Open Access | Times Cited: 276
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 475-495
Open Access | Times Cited: 251
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1137-1146
Open Access | Times Cited: 90
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Complement activation in COVID-19 and targeted therapeutic options: A scoping review
Endry H. T. Lim, Rombout B. E. van Amstel, Vieve Victoria de Boer, et al.
Blood Reviews (2022) Vol. 57, pp. 100995-100995
Open Access | Times Cited: 46
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome
Robert F. J. Kullberg, Justin de Brabander, Leonoor S. Boers, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 7, pp. 846-856
Open Access | Times Cited: 40
Tissue factor in COVID-19-associated coagulopathy
Saravanan Subramaniam, Hema Kothari, Markus Bosmann
Thrombosis Research (2022) Vol. 220, pp. 35-47
Open Access | Times Cited: 37
Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study
Felix P. Chilunga, Brent Appelman, Michèle van Vugt, et al.
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100630-100630
Open Access | Times Cited: 30
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
Justin de Brabander, Leonoor S. Boers, Robert F. J. Kullberg, et al.
Thorax (2023) Vol. 78, Iss. 9, pp. 912-921
Open Access | Times Cited: 25
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View
Daniela Alfano, Paola Franco, Maria Patrizia Stoppelli
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)
Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 217, pp. 114827-114827
Open Access | Times Cited: 30
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Justin de Brabander, Erik Duijvelaar, Job R. Schippers, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2200780-2200780
Open Access | Times Cited: 28
The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
Anna Paola Capra, Alessio Ardizzone, Giuseppe Pantò, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3537-3537
Open Access | Times Cited: 19
Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients
Thei S. Steenvoorden, Koen C. de Kruijf, Brent Appelman, et al.
Critical Care Explorations (2025) Vol. 7, Iss. 3, pp. e1222-e1222
Open Access
RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19
Katherine D. Wick, Lianne Siegel, James D. Neaton, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 23
Serum biomarkers associated with SARS-CoV-2 severity
Fabiani de Morais Batista, Marco Antonio Moreira Puga, Patrícia Vieira da Silva, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Biomarkers Associated with Cardiovascular Disease in COVID-19
Christoph C. Kaufmann, Amro Ahmed, Achim Leo Burger, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 922-922
Open Access | Times Cited: 22
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
Manuela Rizzi, Davide D’Onghia, Stelvio Tonello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7099-7099
Open Access | Times Cited: 14
Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review
Rachael Cusack, Lieuwe D. J. Bos, Pedro Póvoa, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
Manuela Rizzi, Stelvio Tonello, Davide D’Onghia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 951-951
Open Access | Times Cited: 12
Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS
Owen Richards, Philip Pallmann, Charles C. King, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1425-1425
Open Access | Times Cited: 27
COVID-19 Pathophysiology: An Opportunity to Start Appreciating Time-Dependent Variation
Lonneke A. van Vught, Lieuwe D. J. Bos
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 5, pp. 483-485
Open Access | Times Cited: 21
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
David de Gonzalo‐Calvo, Marta Molinero, Iván D. Benítez, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention
David R. Sweet, Michael L. Freeman, David A. Zidar
Pathogens and Immunity (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top